What Is Cardiac Arrest?

Cardiac arrest is the sudden cessation of effective mechanical pumping activity in the heart, resulting in the immediate loss of blood flow to the brain and other vital organs. It is distinct from a heart attack, which is a blockage of coronary blood supply; cardiac arrest is an electrical event in which the heart's coordinated contraction fails entirely or degenerates into a chaotic, ineffective rhythm. Without intervention, loss of consciousness occurs within seconds and irreversible brain injury begins within four to six minutes.

The clinical and biomedical engineering study of cardiac arrest spans cardiology, emergency medicine, bioelectric signal processing, and device design. The mechanisms of arrest, the instrumentation used to detect and reverse it, and the monitoring systems deployed in hospitals and public spaces all involve engineering contributions grounded in electrophysiology and biomedical measurement.

Electrophysiological Mechanisms

The most common underlying arrhythmia in out-of-hospital cardiac arrest among adults is ventricular fibrillation (VF), in which multiple independent re-entrant electrical wavelets depolarize the ventricular myocardium in a disorganized pattern. This produces rapid, chaotic electrical activity visible on an electrocardiogram (ECG) and entirely ineffective mechanical contraction. Ventricular tachycardia without a pulse (pulseless VT) is a related mechanism. Pulseless electrical activity (PEA), in which organized electrical signals occur without adequate mechanical output, and asystole, a complete absence of electrical activity, account for a substantial portion of arrests with non-shockable rhythms. As documented in NIH's Cardiac Arrest StatPearls entry, the initial rhythm determines both the prognosis and the treatment pathway.

Defibrillation and Resuscitation

Defibrillation is the definitive treatment for VF and pulseless VT. A defibrillator delivers a controlled electrical shock, typically 150 to 360 joules in biphasic devices, that simultaneously depolarizes a critical mass of the myocardium, briefly terminating all cardiac electrical activity and allowing the heart's intrinsic sinoatrial node to reassert a normal rhythm. As the NHLBI explains in its overview of defibrillators, the intervention must be delivered promptly because the probability of successful defibrillation falls by roughly 10 percent for each minute of delay. Automated external defibrillators (AEDs) are engineered to allow bystanders without clinical training to apply the therapy; onboard algorithms analyze the surface ECG and withhold the shock if the rhythm is not shockable, reducing the risk of inappropriate therapy. Cardiopulmonary resuscitation (CPR) maintains a minimum of coronary and cerebral perfusion between defibrillation attempts and is a critical bridge to the return of spontaneous circulation. Clinical protocols for post-arrest care, including targeted temperature management and coronary angiography, are addressed in the PMC review of cardiac arrest resuscitation and reperfusion.

Monitoring and Detection Technologies

Early detection of cardiac arrest, both inside and outside the hospital, relies on continuous ECG monitoring systems, implantable cardioverter-defibrillators (ICDs), and wearable cardiac monitors. ICDs continuously analyze the intracardiac electrogram and deliver therapy within seconds of detecting a shockable rhythm, without requiring external intervention. Signal processing algorithms embedded in these devices distinguish VF from artifact, oversensing, and supraventricular arrhythmias to minimize inappropriate shocks.

Applications

The study and technology of cardiac arrest has applications in a wide range of fields, including:

• Design of automated external defibrillators and implantable cardioverter-defibrillators
• Wearable and remote cardiac monitoring systems
• Hospital telemetry and early warning scoring systems
• Emergency dispatch systems using telephone-guided bystander CPR
• Cardiac arrest registry and epidemiological data platforms